Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Newsom

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Hematopathology|September 19, 2024
Pathogenic variants of mycosis fungoides identified using next-generation sequencingSunaina Shrestha, Kimberly Newsom, Joanna Melody Chaffin, et al.
Journal of Clinical Laboratory Analysis|July 2, 2021
The Hologic Aptima SARS-CoV-2 assay enables high ratio pooling saving reagents and improving turnaround timeKimberly Newsom, Yuan Zhang, Srikar Chamala, et al.
Journal of Pathology Informatics|September 18, 2023
Automated HL7v2 LRI informatics framework for streamlining genomics-EHR data integrationRobert H Dolin, Rohan Gupta, Kimberly Newsom, et al.
Electrophoresis|November 20, 2012
In vitro MS-based proteomic analysis and absolute quantification of neuronal-glial injury biomarkers in cell culture systemJoy D Guingab-Cagmat, Kimberly Newsom, Anatoliy Vakulenko, et al.
Histopathology|June 10, 2020
Malignant round cell tumor with SS18-POU5F1 fusion: is it a myoepithelial neoplasm, a synovial sarcoma or a new entity?Archana Shenoy, Kimberly Newsom, Brian Gray, et al.
Journal of Translational Medicine|April 13, 2018
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary interventionLarisa H Cavallari, Francesco Franchi, Fabiana Rollini, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 24, 2019
CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trialD Max Smith, Kristin W Weitzel, Amanda R Elsey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung CancerJulia K Rotow, Philippe Gui, Wei Wu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Hematopathology|September 19, 2024
Pathogenic variants of mycosis fungoides identified using next-generation sequencingSunaina Shrestha, Kimberly Newsom, Joanna Melody Chaffin, et al.
Journal of Clinical Laboratory Analysis|July 2, 2021
The Hologic Aptima SARS-CoV-2 assay enables high ratio pooling saving reagents and improving turnaround timeKimberly Newsom, Yuan Zhang, Srikar Chamala, et al.
Journal of Pathology Informatics|September 18, 2023
Automated HL7v2 LRI informatics framework for streamlining genomics-EHR data integrationRobert H Dolin, Rohan Gupta, Kimberly Newsom, et al.
Electrophoresis|November 20, 2012
In vitro MS-based proteomic analysis and absolute quantification of neuronal-glial injury biomarkers in cell culture systemJoy D Guingab-Cagmat, Kimberly Newsom, Anatoliy Vakulenko, et al.
Histopathology|June 10, 2020
Malignant round cell tumor with SS18-POU5F1 fusion: is it a myoepithelial neoplasm, a synovial sarcoma or a new entity?Archana Shenoy, Kimberly Newsom, Brian Gray, et al.
Journal of Translational Medicine|April 13, 2018
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary interventionLarisa H Cavallari, Francesco Franchi, Fabiana Rollini, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 24, 2019
CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trialD Max Smith, Kristin W Weitzel, Amanda R Elsey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung CancerJulia K Rotow, Philippe Gui, Wei Wu, et al.
Pageof 1